Delivery Order SPE2DB20D2014-SPE2DB25FC58Z
- Not listed
- The Defense Logistics Agency awarded a $2,198.43 delivery order to AmerisourceBergen Drug Corp for Lo Loestrin FE 1-10 tablets (28-count packages) on June 18, 2025, with an ultimate completion date of June 20, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,398.34 to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablets (28-count package) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a supply of a brand-name oral contraceptive medication. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Lo Loestrin Fe 1-10 Tablet 28s, a hormonal contraceptive medication. This firm fixed-price delivery order, valued at $1,497.08, represents a non-competitive award and is part of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government. The order is scheduled for completion by September 16, 2025, with performance occurring at the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,560.38 to AmerisourceBergen Drug Corp for Lo Loestrin FE 1-10 Tablet 28s, a hormonal contraceptive medication. The contract, awarded on September 2, 2025, with an ultimate completion date of September 3, 2025, utilizes firm fixed pricing with no set-aside designation, indicating competitive award. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Lo Loestrin FE 1-10 tablets (28-count packaging) with a ceiling value of $3,613.04. This is a firm fixed-price delivery order with an ultimate completion date of June 23, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order valued at $37,032.75 to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablet 28-count units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 3, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply...
- The Defense Logistics Agency awarded a delivery order valued at $1,288.60 to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 Tablet 28s, a hormonal contraceptive medication. The contract, awarded on August 6, 2025, with an ultimate completion date of August 7, 2025, utilizes firm fixed pricing with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a $3,216.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Lo Loestrin FE 1-10 Tablet 28s, a hormonal contraceptive medication. The contract represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. Performance will be completed by July 15, 2025, with services provided...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,787.85 to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Lo Loestrin Fe 1-10 tablets (28-count packages). This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was competitively awarded without set-aside provisions and will...
- The Defense Logistics Agency awarded a delivery order valued at $10,943.58 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Lo Loestrin Fe 1-10 Tablet 28-count packages. This competitive award, utilizing firm fixed pricing with no set-aside designation, represents a continuation of pharmaceutical procurement under the company's broader contractual relationship with the federal government. The product will be delivered to AmerisourceBergen's corporate office location in...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC58ZDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,633.09 to AmerisourceBergen Drug Corp for Lo Loestrin FE 1-10 Tablet 28s, a hormonal contraceptive medication. This firm fixed-price delivery order, issued on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a non-competitive award under an existing contract vehicle. The product will be delivered to the Place of Performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion pharmaceutical prime vendor agreement running through December 2026 that supplies military healthcare systems globally. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for the Defense Health Agency and other federal healthcare programs, fulfilling requirements for brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The DLA Troop Support is transitioning to Pharmaceutical Prime Vendor Global Program Generation V contracts with plans for multiple regional awards, positioning AmerisourceBergen Drug Corp as a key strategic partner in the military's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.6k | 7/28/25 |